Logo image of AUR

AURORA INNOVATION INC (AUR) Stock Fundamental Analysis

NASDAQ:AUR - Nasdaq - US0517741072 - Common Stock - Currency: USD

6.09  -0.07 (-1.14%)

Fundamental Rating

3

Overall AUR gets a fundamental rating of 3 out of 10. We evaluated AUR against 282 industry peers in the Software industry. AUR has a great financial health rating, but its profitability evaluates not so good. AUR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AUR had negative earnings in the past year.
AUR had a negative operating cash flow in the past year.
AUR had negative earnings in each of the past 5 years.
In the past 5 years AUR always reported negative operating cash flow.
AUR Yearly Net Income VS EBIT VS OCF VS FCFAUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -500M -1B -1.5B

1.2 Ratios

AUR has a worse Return On Assets (-38.19%) than 79.08% of its industry peers.
The Return On Equity of AUR (-44.31%) is worse than 66.31% of its industry peers.
Industry RankSector Rank
ROA -38.19%
ROE -44.31%
ROIC N/A
ROA(3y)-52.24%
ROA(5y)-42.37%
ROE(3y)-58.86%
ROE(5y)-48.65%
ROIC(3y)N/A
ROIC(5y)N/A
AUR Yearly ROA, ROE, ROICAUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AUR Yearly Profit, Operating, Gross MarginsAUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

More info and screens

8

2. Health

2.1 Basic Checks

The number of shares outstanding for AUR has been increased compared to 1 year ago.
The number of shares outstanding for AUR has been increased compared to 5 years ago.
There is no outstanding debt for AUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AUR Yearly Shares OutstandingAUR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
AUR Yearly Total Debt VS Total AssetsAUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

AUR has an Altman-Z score of 19.11. This indicates that AUR is financially healthy and has little risk of bankruptcy at the moment.
AUR has a Altman-Z score of 19.11. This is amongst the best in the industry. AUR outperforms 92.55% of its industry peers.
There is no outstanding debt for AUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 19.11
ROIC/WACCN/A
WACCN/A
AUR Yearly LT Debt VS Equity VS FCFAUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 9.54 indicates that AUR has no problem at all paying its short term obligations.
AUR has a Current ratio of 9.54. This is amongst the best in the industry. AUR outperforms 94.33% of its industry peers.
AUR has a Quick Ratio of 9.54. This indicates that AUR is financially healthy and has no problem in meeting its short term obligations.
AUR has a better Quick ratio (9.54) than 94.33% of its industry peers.
Industry RankSector Rank
Current Ratio 9.54
Quick Ratio 9.54
AUR Yearly Current Assets VS Current LiabilitesAUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.08% over the past year.
EPS 1Y (TTM)4.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

AUR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.06% yearly.
Based on estimates for the next years, AUR will show a very strong growth in Revenue. The Revenue will grow by 531.08% on average per year.
EPS Next Y-1.81%
EPS Next 2Y1.11%
EPS Next 3Y4.97%
EPS Next 5Y22.06%
Revenue Next Year1990.1%
Revenue Next 2Y1352.17%
Revenue Next 3Y1046.29%
Revenue Next 5Y531.08%

3.3 Evolution

AUR Yearly Revenue VS EstimatesAUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2021 2022 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
AUR Yearly EPS VS EstimatesAUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AUR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AUR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AUR Price Earnings VS Forward Price EarningsAUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AUR Per share dataAUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.11%
EPS Next 3Y4.97%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AUR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AURORA INNOVATION INC

NASDAQ:AUR (8/6/2025, 12:14:05 PM)

6.09

-0.07 (-1.14%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-30 2025-10-30/amc
Inst Owners69.8%
Inst Owner Change0.27%
Ins Owners1.33%
Ins Owner Change1.93%
Market Cap10.77B
Analysts74.29
Price Target10.43 (71.26%)
Short Float %10.55%
Short Ratio4.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.77%
Min EPS beat(2)-2.93%
Max EPS beat(2)4.46%
EPS beat(4)2
Avg EPS beat(4)0.34%
Min EPS beat(4)-12.17%
Max EPS beat(4)11.99%
EPS beat(8)5
Avg EPS beat(8)6.65%
EPS beat(12)8
Avg EPS beat(12)4.44%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)18.18%
EPS NQ rev (1m)-1.21%
EPS NQ rev (3m)-1.69%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-27.71%
Revenue NY rev (1m)-2.18%
Revenue NY rev (3m)-16.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 6.03
P/tB 9.22
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0
BVpS1.01
TBVpS0.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.19%
ROE -44.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-52.24%
ROA(5y)-42.37%
ROE(3y)-58.86%
ROE(5y)-48.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 154.54%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.54
Quick Ratio 9.54
Altman-Z 19.11
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)100.51%
Cap/Depr(5y)164.87%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
EPS Next Y-1.81%
EPS Next 2Y1.11%
EPS Next 3Y4.97%
EPS Next 5Y22.06%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year1990.1%
Revenue Next 2Y1352.17%
Revenue Next 3Y1046.29%
Revenue Next 5Y531.08%
EBIT growth 1Y1.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.79%
EBIT Next 3Y7.78%
EBIT Next 5Y22.78%
FCF growth 1Y-22.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.65%
OCF growth 3YN/A
OCF growth 5YN/A